Cytiva Cell & Gene Tech Expo April 2026: Gene Therapy

Gene therapy developers are under increasing pressure to advance programs quickly while managing cost, ensuring quality, and preparing for scale. In this session, Cytiva will share how smart manufacturing decisions—made early and supported by the right technologies and partnerships—can set gene therapy programs up for success.

We’ll highlight integrated upstream and downstream solutions and scalable platforms designed to support viral vector process development, transfer, and scale‑up. Key challenges such as maintaining consistency and yield, optimizing bioreactor performance, and meeting regulatory expectations will be addressed, along with practical strategies to reduce risk and accelerate the path to commercialization.

Join us to learn how collaborative expertise and fit‑for‑purpose manufacturing approaches can help expand patient access to gene therapies.

About Cytiva

Gene therapy programs move fast, and Cytiva is built to keep pace. By combining scientific expertise with regulatory and manufacturing insight, we help reduce rework, speed timelines, and bring therapies to patients sooner. Wherever your program is headed, we’re here to help you move forward with confidence.